Philly Vax Team at Cookout


September 17, 2017

We’re hoping to excite you about our work and to introduce you to who we are as a research team dedicated to ending the HIV epidemic. In the future, you will find interviews with staff members and clinical trial participants, explanations of the science and logic behind our clinical trials, news about community events, and much more.

Read More
AMP Logo

AMP Study

September 8, 2017

The AMP Study (also known as HVTN 704/HPTN 085) tests an experimental antibody against HIV. AMP stands for Antibody Mediated Prevention. Read more about the AMP Study

Read More
Philly Vax Team

Who we are

August 10, 2017

The University of Pennsylvania HIV Clinical Trials Unit (UPenn HIV CTU) is a leader in HIV prevention, research, and education.

Read More
HIV Prevention Research Studies - Give PrEP A Shot - 1-866-448-7366

Research studies focused on preventing HIV infection

August 7, 2017

The research mission of the UPENN Clinical Trials Unit is to develop and conduct scientific research studies that discover how to treat or prevent HIV infection. We value our diverse study volunteers and build local and global partnerships with communities, scientists, and policymakers. we strive to make our clinic volunteer-focused and friendly, understanding that our…

Read More
Video: The Future of HIV Vaccine Development

The Future of HIV Vaccine Development

May 3, 2017

Experts are “cautiously optimistic.” Drs. Larry Corey and Diane Havlir discuss what it will take to get to zero HIV infections worldwide at the Fortune Brainstorm Health conference, May 2nd, 2017. San Diego. © 2017 Time Inc. All rights reserved.

Read More